News

Pictured: Hans-Guido Wendel
Genetic Causes of Blood Cancers Explored

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.

Tuesday, December 20, 2011
Pictured: Structural formula of IBNtxA
Findings Could Lead to the Development of a New Painkiller

Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.

Tuesday, December 13, 2011
Research Suggests Potential Immune Therapy for Preventing Breast Cancer Metastasis

A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.

Friday, December 9, 2011
Pictured: Breast tumor treated with paclitaxel
Research Suggests New Drugs Could Boost the Effectiveness of Chemotherapy

Recent findings by Memorial Sloan Kettering investigators suggest it might be possible to improve the effectiveness of chemotherapy for breast cancer by combining the treatment with a new type of drug called a cathepsin inhibitor.

Friday, December 2, 2011
Pictured: David Solit
Researchers Discover Why New Melanoma Drug Stops Working

Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug, vemurafenib.

Wednesday, November 23, 2011
Pictured: Semanti Mukherjee
Semanti Mukherjee Successfully Defends Thesis

Semanti Mukherjee successfully defended her thesis in September 2011. Her project focused on the genetic variants that contribute to the predisposition for and etiology of myeloproliferative neoplasms.

Tuesday, November 1, 2011
Memorial Sloan Kettering Researchers Discover How Gene Mutation Contributes to Leukemia

A study led by researchers at Memorial Sloan Kettering and New York University has shown that TET2 loss enhances the function of blood stem cells, causing them to renew themselves more efficiently than normal blood stem cells.

Friday, October 21, 2011
Pictured: Alison Spencer
Frontiers of Science Symposium

Gerstner Sloan Kettering sponsored a daylong symposium for undergraduates and their faculty advisors to meet Gerstner Sloan Kettering leaders and graduate students while enjoying faculty talks, student posters, and a visit to Memorial Sloan Kettering research facilities.

Thursday, October 20, 2011
Pictured: Eric Alonzo
Eric Alonzo Successfully Defends Thesis

Eric Alonzo successfully defended his thesis in September 2011. He completed his dissertation research in the laboratory of Dr. Derek Sant’Angelo in the Immunology Program.

Saturday, October 15, 2011
Pictured: Douglas Levine
Genomic Analysis Provides Clues about Most Common Form of Ovarian Cancer

In a large-scale genomic analysis of the most common and aggressive type of ovarian cancer, researchers from Memorial Sloan Kettering and other centers identified genetic mutations and pathways that set the disease apart from other types of ovarian cancer and other solid tumors.

Tuesday, October 11, 2011